The monoclonal antibody omalizumab reduces the risk of exacerbations by about 25% over the course of a year among patients with more severe, persistent asthma.
Change in mammographic density may be a useful intermediate marker of increased breast cancer risk in postmenopausal women using estrogen and progestin therapy (EPT). This was the finding of a case-controlled study conducted as part of the Women’s Health Initiative (WHI) study.
With collective bargaining set to begin, Linda Haslam-Stroud cites recent poll indicating Ontarians feel a wage freeze would increase wait times, worsen nursing shortage.
